Novo Nordisk A/S (NONOF)
49.02
-0.50
(-1.01%)
USD |
OTCM |
Feb 11, 16:00
Novo Nordisk EPS Diluted (Quarterly) : 0.9419 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| Hims & Hers Health, Inc. | 0.0634 |
| Genmab A/S | 0.6431 |
| Ascendis Pharma A/S | -1.173 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.191B |
| Revenue (Quarterly) | 12.33B |
| Total Expenses (Quarterly) | 8.143B |
| Enterprise Value | 234.32B |
| Gross Profit Margin (Quarterly) | 80.86% |
| Profit Margin (Quarterly) | 33.98% |
| Earnings Yield | 7.08% |
| Operating Earnings Yield | 8.82% |
| Normalized Earnings Yield | 7.075 |